BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22964562)

  • 1. Impact of estrogen replacement throughout childhood on growth, pituitary-gonadal axis and bone in a 46,XX patient with CYP19A1 deficiency.
    Janner M; Flück CE; Mullis PE
    Horm Res Paediatr; 2012; 78(4):261-8. PubMed ID: 22964562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian and uterine development and hormonal feedback mechanism in a 46 XX patient with CYP19A1 deficiency under low dose estrogen replacement.
    Burckhardt MA; Obmann V; Wolf R; Janner M; Flück CE; Mullis PE
    Gynecol Endocrinol; 2015 May; 31(5):349-54. PubMed ID: 25585547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism.
    Chen Z; Wang O; Nie M; Elison K; Zhou D; Li M; Jiang Y; Xia W; Meng X; Chen S; Xing X
    Mol Cell Endocrinol; 2015 Jan; 399():32-42. PubMed ID: 25301327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency.
    Verma N; Jain V; Birla S; Jain R; Sharma A
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1185-90. PubMed ID: 23329769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment.
    Lanfranco F; Zirilli L; Baldi M; Pignatti E; Corneli G; Ghigo E; Aimaretti G; Carani C; Rochira V
    Bone; 2008 Sep; 43(3):628-35. PubMed ID: 18590994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase deficiency, a rare syndrome: case report.
    Baykan EK; Erdoğan M; Özen S; Darcan Ş; Saygılı LF
    J Clin Res Pediatr Endocrinol; 2013; 5(2):129-32. PubMed ID: 23748068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase deficiency in a male patient - Case report and review of the literature.
    Miedlich SU; Karamooz N; Hammes SR
    Bone; 2016 Dec; 93():181-186. PubMed ID: 27693882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood.
    Mullis PE; Yoshimura N; Kuhlmann B; Lippuner K; Jaeger P; Harada H
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1739-45. PubMed ID: 9177373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase and estrogen receptor α deficiency.
    Bulun SE
    Fertil Steril; 2014 Feb; 101(2):323-9. PubMed ID: 24485503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic basis of aromatase excess syndrome: recombination- and replication-mediated rearrangements leading to CYP19A1 overexpression.
    Fukami M; Tsuchiya T; Vollbach H; Brown KA; Abe S; Ohtsu S; Wabitsch M; Burger H; Simpson ER; Umezawa A; Shihara D; Nakabayashi K; Bulun SE; Shozu M; Ogata T
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E2013-21. PubMed ID: 24064691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of long-term raloxifene and estradiol treatments on bone in a patient with congenital aromatase deficiency.
    Zirilli L; Maffei L; Meunier PJ; Chavassieux P; Carani C; Rochira V
    Bone; 2009 Nov; 45(5):827-32. PubMed ID: 19345749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogen replacement therapy on bone and glucose metabolism in a male with congenital aromatase deficiency.
    Herrmann BL; Janssen OE; Hahn S; Broecker-Preuss M; Mann K
    Horm Metab Res; 2005 Mar; 37(3):178-83. PubMed ID: 15824973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary function in a man with congenital aromatase deficiency: effect of different doses of transdermal E2 on basal and stimulated pituitary hormones.
    Rochira V; Balestrieri A; Faustini-Fustini M; Borgato S; Beck-Peccoz P; Carani C
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2857-62. PubMed ID: 12050263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five new cases of 46,XX aromatase deficiency: clinical follow-up from birth to puberty, a novel mutation, and a founder effect.
    Marino R; Perez Garrido N; Costanzo M; Guercio G; Juanes M; Rocco C; Ramirez P; Warman DM; Ciaccio M; Pena G; Feyling JG; Miras M; Rivarola MA; Belgorosky A; Saraco N
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E301-7. PubMed ID: 25415177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase excess syndrome: a rare autosomal dominant disorder leading to pre- or peri-pubertal onset gynecomastia.
    Fukami M; Miyado M; Nagasaki K; Shozu M; Ogata T
    Pediatr Endocrinol Rev; 2014 Mar; 11(3):298-305. PubMed ID: 24716396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen deficiency reversibly induces telomere shortening in mouse granulosa cells and ovarian aging in vivo.
    Bayne S; Li H; Jones ME; Pinto AR; van Sinderen M; Drummond A; Simpson ER; Liu JP
    Protein Cell; 2011 Apr; 2(4):333-46. PubMed ID: 21574023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).
    Conte FA; Grumbach MM; Ito Y; Fisher CR; Simpson ER
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1287-92. PubMed ID: 8200927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene.
    Belgorosky A; Pepe C; Marino R; Guercio G; Saraco N; Vaiani E; Rivarola MA
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5127-31. PubMed ID: 14602738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An aroma of complexity: how the unique genetics of aromatase (CYP19A1) explain diverse phenotypes from hens and hyenas to human gynecomastia, and testicular and other tumors.
    Stratakis CA
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4676-81. PubMed ID: 24311795
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene.
    Herrmann BL; Saller B; Janssen OE; Gocke P; Bockisch A; Sperling H; Mann K; Broecker M
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5476-84. PubMed ID: 12466340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.